FDA To Study Toll-Free Numbers In Rx Television Ads

Comments on a study examining the impact on consumer comprehension of inclusion of a toll-free number to report side effects in direct-to-consumer (DTC) prescription drug television advertisements are being sought by FDA. The study will examine the placement of the toll-free statement and the length of time the statement is presented on-screen in a DTC television advertisement for a prescription drug. Federal Register Pre-Publication Notice